Mark Froimson Pacira Bio Sciences, Inc. (PCRX) insider trading activity

PCRX Quotes by TradingView

Mark Froimson is Director of Pacira BioSciences, Inc.. Currently has a direct ownership of 13,073 shares of PCRX, which is worth approximately $374,018. The most recent transaction as insider was on Jun 12, 2024, when has been sold 5,230 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.1K
66.68% 3M change
66.68% 12M change
Total Value Held $374,018

Mark Froimson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
5,230 Added 28.57%
13,073 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
1,775 Added 18.45%
7,843 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
1,160 Added 16.05%
6,068 Common Stock
May 09 2022
SELL
Open market or private sale
$59,370 $59.37 p/Share
1,000 Reduced 16.93%
4,908 Common Stock
Dec 17 2021
SELL
Bona fide gift
-
400 Reduced 6.34%
5,908 Common Stock
Jun 09 2021
BUY
Grant, award, or other acquisition
-
1,066 Added 14.46%
6,308 Common Stock
Mar 15 2021
SELL
Open market or private sale
$53,039 $72.26 p/Share
734 Reduced 12.28%
5,242 Common Stock
MF

Mark Froimson

Director
Tampa, FL

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCRX